Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7364 p243
27 August 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Patient packs


Society wants Department of Health to introduce policy of dispensing medicines in original packs

Splitting medicines' original packaging can undermine patient safety

Splitting medicines’ original packaging can undermine patient safety

Original pack dispensing

OPD is standard in most of the EU, apart from in the UK where about 45 per cent of prescriptions are dispensed from bulk or split packs. All new medicines licensed after 30 October will have to be in packs that bear their names, strength and dosage form in Braille. Braille readers will only benefit from this if medicines are dispensed in their original packaging.

Full implementation of original pack dispensing (OPD) is to be sought by the Royal Pharmaceutical Society — a move supported by other pharmacy organisations.

Following a decision of the Society’s Council this month (PJ, 13 August, p200), the Society is to try to persuade the Department of Health to redirect funding to support full implementation of OPD except where it is not in the best interest of individual patients.

The Society’s head of practice, Sue Kilby, said: “The Society has supported in principle original pack dispensing for some years. To date there has been a certain amount of reluctance to bring in original pack dispensing as standard practice, largely because of the perceived cost implications. However, the Society believes the introduction of original pack dispensing will have a number of benefits. In particular, patients will receive their medicines in packs which have the relevant patient information leaflet, this will provide patients with information on how to take and store their medicines and they will also be aware of any potential side effects, interactions or contraindications.”

The Society’s decision has the support of the National Pharmacy Association, which called for full implementation of OPD at the beginning of July.

An NPA statement said: “Patients have a right to expect to receive the same service as other European citizens and will expect to be given medicines in the patient packs designed for them by the manufacturers. The Government cannot ignore this issue any longer. Pharmacists sit between a rock and a hard place on this issue and patient safety is being undermined. The Government needs to face up to its obligations, put its hand in its pocket, and make the regulatory changes necessary to allow for the routine use of patient packs.”

Lindsay McClure, head of information at the Pharmaceutical Services Negotiating Committee, said: “In the course of the new contract negotiations we have discussed the need to move, as far as practicable, to patient pack dispensing. Both the PSNC and the Department of Health recognise that this cannot be a comprehensive move but we expect to make progress on this in the near future.”

She added that previous discussions over many years had collapsed because the NHS refused to indemnify contractors against the costs of making the transition.

“We need to ensure that implementation of patient pack dispensing does not lead to a loss for contractors,” she said.

Wendy Harris, senior pharmacist at the National Patient Safety Agency, added: “The NPSA welcomes any initiative to ensure that patients receive the original manufacturers’ packs, to assist them in differentiating between their different medicines and preventing opportunities for harm directly attributable to the packaging. Patients currently receive medicines from a variety of locations within the NHS, and provided by numerous professionals.” She added that the medicines are often removed from the original packaging and supplied to the patient in undifferentiated and poorly labelled containers. “Consequently...a patient may receive some or all of their medicines in lookalike packaging and labelling, providing little visual clue for identification of the correct medicine.”

A spokesman for the Association of the British Pharmaceutical Industry said that OPD is something it has long been campaigning for. “OPD helps ensure product integrity and that patients receive vital information leaflets with every pack. With the Royal Pharmaceutical Society on board OPD will hopefully soon become a reality.”

Proposals that would have led to the implementation of original pack dispensing in the UK were put forward early in 1997 by the then Conservative government. But they were killed off on cost grounds later that year after the election of a Labour government (PJ, 15 November 1997, p794).

Back to Top


©The Pharmaceutical Journal